We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$170B
1-Year Est. Return
46.21%
This Fund
S&P 500
This Quarter
Est. Return
+6.72%
1 Year Est. Return
+46.21%
3 Year Est. Return
+117.8%
5 Year Est. Return
+135.17%
10 Year Est. Return
+586.77%
AUM
$34B
AUM Growth
+$4.4B
(+15%)
Cap. Flow
+$3.11B
Cap. Flow
% of AUM
9.14%
Top 10 Holdings %
Top 10 Hldgs %
11.75%
Holding
2,403
New
160
Increased
1,020
Reduced
1,025
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$308M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$249M |
| 3 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$221M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$217M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$96.7M |
| 2 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$85M |
| 3 |
AGN
Allergan Inc
AGN
|
+$64.4M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$58.1M |
| 5 |
PepsiCo
PEP
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.89% |
| 2 | Miscellaneous | 13.15% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Technology | 11.05% |
| 5 | Consumer Staples | 8.32% |
Similar funds
First Trust Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, First Trust Advisors held 2,403 positions worth $34B, up 15% from $29.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
First Trust Advisors deployed $3.11B of net new capital in Q1 2015, opening 160 new positions and adding to 1,020 existing holdings. Its largest new stake was Novavax: 705,902 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was PepsiCo, an estimated $54.5M trimmed.
- First Trust Advisors's largest Q1 2015 buy was Novavax: 705,902 shares worth $117M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q1 2015, an estimated $308M increase.
- First Trust Advisors's biggest Q1 2015 reduction was PepsiCo, cutting an estimated $54.5M.
- First Trust Advisors fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $96.7M.
- First Trust Advisors's ten largest holdings make up 12% of its $34B portfolio in Q1 2015.
- First Trust Advisors opened 160 new positions and closed 188 in Q1 2015.
- First Trust Advisors's portfolio value rose 15% quarter-over-quarter to $34B.
Based on First Trust Advisors's 13F filing for Q1 2015, filed 4 May 2015.